MAIA Biotechnology, Inc. - MAIA

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$14.05M

QoQ value delta ($000)

+$9.974M (+244.52%)

Implied price effect (QoQ)

-12.81%

Total shares

9,945,011

QoQ shares delta

+7,428,207 (+295.14%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 25 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Solas Capital Management, LLC	6,015	4,297,004	3.46%
VANGUARD CAPITAL MANAGEMENT LLC	2,903	2,074,045	0.0%
VANGUARD GROUP INC	1,766	1,154,833	0.0%
Centric Wealth Management	1,107	796,723	0.22%
Bleichroeder LP	700	500,000	0.12%
GEODE CAPITAL MANAGEMENT, LLC	504	360,481	0.0%
VANGUARD FIDUCIARY TRUST CO	279	199,314	0.0%
STATE STREET CORP	194	138,950	0.0%
BlackRock, Inc.	179	127,978	0.0%
NORTHERN TRUST CORP	73	52,539	0.0%
UBS Group AG	72	51,917	0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC	50	36,000	0.0%
Creative Planning	40	28,602	0.0%
RITHOLTZ WEALTH MANAGEMENT	32	23,071	0.0%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	28	20,071	0.0%
Centerpoint Advisory Group	22	15,730	0.02%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	19	14,800	0.0%
Cambridge Investment Research Advisors, Inc.	15	10,620	0.0%
Vanguard Global Advisers, LLC	15	11,401	0.0%
Catalyst Funds Management Pty Ltd	15	10,800	0.0%
OSAIC HOLDINGS, INC.	11	8,334	0.0%
Daytona Street Capital LLC	10	7,500	0.01%
CURIO WEALTH, LLC	2	2,000	0.0%
MORGAN STANLEY	1	1,000	0.0%
MAI Capital Management	1	675	0.0%